VEGF Trap in Treating Patients With Solid Tumors or Non-Hodgkin's Lymphoma
Part of paid clinical trials in New York, New York.
- Sponsor
- Regeneron Pharmaceuticals
- Study ID
- NCT00045266
- Phase
- PHASE1
- Status
- Completed
Conditions
- Lymphoma
- Unspecified Adult Solid Tumor, Protocol Specific
Eligibility Criteria
- Sex
- ALL
- Age
- 25 Years - 120 Years
- Healthy Volunteers
- Not accepted
Interventions
- ziv-aflibercept — BIOLOGICAL
Study Details
RATIONALE: VEGF Trap may stop the growth of solid tumors or non-Hodgkin's lymphoma by stopping blood flow to the cancer. PURPOSE: Phase I trial to study the effectiveness of VEGF Trap in treating patients who have relapsed or refractory solid tumors or non-Hodgkin's lymphoma.
Key Dates
- Start date
- Apr 30, 2002
- Status verified
- Jun 2016
- Primary completion
- Feb 28, 2007
Study Design
- Primary purpose
- TREATMENT
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10021 | - |
Find similar trials in New York, NY
By research site
Related Studies
- Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative DisordersRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and LymphomaRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado
- Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Miami, Florida